Home » Stocks » FREQ

Frequency Therapeutics, Inc. (FREQ)

Stock Price: $7.80 USD -0.22 (-2.74%)
Updated Jul 29, 2021 11:26 AM EDT - Market open
Market Cap 274.44M
Revenue (ttm) 34.37M
Net Income (ttm) -41.97M
Shares Out 34.22M
EPS (ttm) -1.27
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day July 29
Last Price $7.80
Previous Close $8.02
Change ($) -0.22
Change (%) -2.74%
Day's Open 8.01
Day's Range 7.66 - 8.10
Day's Volume 88,264
52-Week Range 7.34 - 58.37

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

Los Angeles, California--(Newsfile Corp. - July 29, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Frequency Therapeutics...

2 hours ago - Newsfile Corp

New York, New York--(Newsfile Corp. - July 29, 2021) - The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders of Frequency Therapeutics, Inc. (NAS...

6 hours ago - Newsfile Corp

NEW YORK, July 28, 2021 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Frequency Therapeutics, Inc. ("Frequency" or the "Company") (NASDAQ: FREQ) and certain ...

16 hours ago - PRNewsWire

New York, New York--(Newsfile Corp. - July 28, 2021) - The Law Offices of Vincent Wong announce that a class action lawsuit has commenced on behalf of investors who purchased Frequency Therapeutics, Inc...

16 hours ago - Newsfile Corp

New York, New York--(Newsfile Corp. - July 28, 2021) -  The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Frequency Therapeutics, Inc. (NASDAQ: FREQ)...

20 hours ago - Newsfile Corp

Boston, Massachusetts--(Newsfile Corp. - July 28, 2021) - The Thornton Law Firm alerts investors who purchased Frequency Therapeutics, Inc. securities (NASDAQ: FREQ) between November 16, 2020 and March ...

22 hours ago - Newsfile Corp

New York, New York--(Newsfile Corp. - July 28, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Freq...

23 hours ago - Newsfile Corp

BENSALEM, Pa., July 28, 2021 /PRNewswire/ -- Law Offices of Howard G.

1 day ago - PRNewsWire

SAN DIEGO--(BUSINESS WIRE)-- #FREQstock--The suit alleges defendants issued false statements re Frequency Therapeutics business & prospects, resulting in its stock trading at inflated prices.

1 day ago - Business Wire

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Frequency Therapeutics To Contact Him Directly To Discuss Their OptionsNew York, New York-...

1 day ago - Newsfile Corp

Philadelphia, Pennsylvania--(Newsfile Corp. - July 27, 2021) - Berger Montague reminds investors of the upcoming deadline of August 2, 2021 for investors to seek lead plaintiff status in a securities fr...

2 days ago - Newsfile Corp

Los Angeles, California--(Newsfile Corp. - July 27, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Frequency Therapeutics...

2 days ago - Newsfile Corp

NEW YORK, July 26, 2021 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Frequency Therapeutics, Inc. (NASDAQ: FREQ) between November 16, 2...

2 days ago - PRNewsWire

San Diego, California--(Newsfile Corp. - July 26, 2021) -  The Frequency Therapeutics, Inc. (NASDAQ: FREQ) class action lawsuit charges Frequency Therapeutics and its CEO with violations of the Securiti...

2 days ago - Newsfile Corp

New York, New York--(Newsfile Corp. - July 26, 2021) -  The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Frequency Therapeutics, Inc. (NASDAQ: FREQ)...

2 days ago - Newsfile Corp

New York, New York--(Newsfile Corp. - July 26, 2021) -  The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Fre...

2 days ago - Newsfile Corp

Philadelphia, Pennsylvania--(Newsfile Corp. - July 26, 2021) - Berger Montague reminds investors of the upcoming deadline of August 2, 2021 for investors to seek lead plaintiff status in a securities fr...

3 days ago - Newsfile Corp

Los Angeles, California--(Newsfile Corp. - July 26, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Frequency Therapeutics...

3 days ago - Newsfile Corp

New York, New York--(Newsfile Corp. - July 23, 2021) - Pomerantz LLP announces that a class action lawsuit has been filed against Frequency Therapeutics, Inc. ("Frequency" or the "Company") (NASDAQ: FRE...

5 days ago - Newsfile Corp

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Frequency Therapeutics To Contact Him Directly To Discuss Their OptionsNew York, New York-...

5 days ago - Newsfile Corp

LOS ANGELES, July 23, 2021 /PRNewswire/ --   Glancy Prongay & Murray LLP ("GPM") reminds investors of the upcoming  August 2, 2021 deadline to file a lead plaintiff motion in the class action filed on b...

5 days ago - PRNewsWire

Philadelphia, Pennsylvania--(Newsfile Corp. - July 23, 2021) - Berger Montague reminds investors of the upcoming deadline of August 2, 2021 for investors to seek lead plaintiff status in a securities fr...

6 days ago - Newsfile Corp

Los Angeles, California--(Newsfile Corp. - July 23, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Frequency Therapeutics...

6 days ago - Newsfile Corp

Boston, Massachusetts--(Newsfile Corp. - July 23, 2021) - The Thornton Law Firm alerts investors that a class action lawsuit has been filed on behalf of investors of Frequency Therapeutics, Inc. (NASDAQ...

6 days ago - Newsfile Corp

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Frequency Therapeutics To Contact Him Directly To Discuss Their OptionsNew York, New York-...

6 days ago - Newsfile Corp

New York, New York--(Newsfile Corp. - July 22, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Frequency Therapeutics, Inc. (NASDAQ: FREQ) ...

6 days ago - Newsfile Corp

San Diego, California--(Newsfile Corp. - July 22, 2021) - The Frequency Therapeutics, Inc. class action lawsuit charges Frequency Therapeutics (NASDAQ: FREQ) and its CEO with violations of the Securitie...

1 week ago - Newsfile Corp

Los Angeles, California--(Newsfile Corp. - July 22, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Frequency Therapeutics...

1 week ago - Newsfile Corp

New York, New York--(Newsfile Corp. - July 21, 2021) - The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders of Frequency Therapeutics, Inc.Share...

1 week ago - Newsfile Corp

San Diego, California and Woburn, Massachusetts--(Newsfile Corp. - July 21, 2021) -  Shareholder rights law firm Robbins LLP reminds investors that a class action has been filed on behalf of all purchas...

1 week ago - Newsfile Corp

New York, New York--(Newsfile Corp. - July 21, 2021) -  The Law Offices of Vincent Wong announce that a class action lawsuit has commenced in the on behalf of investors who purchased Frequency Therapeut...

1 week ago - Newsfile Corp

LOS ANGELES, July 21, 2021 /PRNewswire/ --  The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise acquired F...

1 week ago - PRNewsWire

Los Angeles, California--(Newsfile Corp. - July 21, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Frequency Therapeutics...

1 week ago - Newsfile Corp

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Frequency Therapeutics To Contact Him Directly To Discuss Their OptionsNew York, New York-...

1 week ago - Newsfile Corp

New York, New York--(Newsfile Corp. - July 20, 2021) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Frequency Therapeutics, Inc. (NASDAQ: FREQ) between...

1 week ago - Newsfile Corp

NEW YORK--(BUSINESS WIRE)-- #FREQ--INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Reminds Investors of a Securities Class Action Against Frequency, Inc. (NASDAQ: FREQ) and Deadline

1 week ago - Business Wire

Los Angeles, California--(Newsfile Corp. - July 20, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Frequency Therapeutics...

1 week ago - Newsfile Corp

NEW YORK, July 18, 2021 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Frequency Therapeutics, Inc. ("Frequency" or the "Company") (NASDAQ: FREQ) and certain ...

1 week ago - PRNewsWire

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Frequency Therapeutics To Contact Him Directly To Discuss Their OptionsNew York, New York-...

1 week ago - Newsfile Corp

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Frequency Therapeutics To Contact Him Directly To Discuss Their OptionsNew York, New York-...

1 week ago - Newsfile Corp

NEW YORK--(BUSINESS WIRE)---- $FREQ--The law firm of Kirby McInerney LLP announces that a securities class action lawsuit has been filed in the U.S. District Court for the District of Massachusetts on b...

1 week ago - Business Wire

NEW YORK--(BUSINESS WIRE)--WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Frequency Therapeutics, Inc. (NASDAQ: FREQ) between November 16, 2020 and March...

1 week ago - Business Wire

Los Angeles, California--(Newsfile Corp. - July 16, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Frequency Therapeutics...

1 week ago - Newsfile Corp

New York, New York--(Newsfile Corp. - July 15, 2021) - The Law Offices of Vincent Wong announce that a class action lawsuit has commenced in the on behalf of investors who purchased Frequency Therapeuti...

1 week ago - Newsfile Corp

Boston, Massachusetts--(Newsfile Corp. - July 15, 2021) - The Thornton Law Firm alerts investors that a class action lawsuit has been filed on behalf of investors of Frequency Therapeutics, Inc. (NASDAQ...

2 weeks ago - Newsfile Corp

Los Angeles, California--(Newsfile Corp. - July 15, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Frequency Therapeutics...

2 weeks ago - Newsfile Corp

New York, New York--(Newsfile Corp. - July 14, 2021) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Frequency Therapeutics, Inc. (NASDAQ: FREQ) between...

2 weeks ago - Newsfile Corp

Los Angeles, California--(Newsfile Corp. - July 14, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Frequency Therapeutics...

2 weeks ago - Newsfile Corp

New York, New York--(Newsfile Corp. - July 13, 2021) -  Pomerantz LLP announces that a class action lawsuit has been filed against Frequency Therapeutics, Inc. ("Frequency" or the "Company") (NASDAQ: FR...

2 weeks ago - Newsfile Corp

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Frequency Therapeutics To Contact Him Directly To Discuss Their OptionsNew York, New York-...

2 weeks ago - Newsfile Corp

About FREQ

Frequency Therapeutics, Inc., a clinical-stage biotechnology company, focuses on harnessing the body's innate biology to repair or reverse damage caused by a range of degenerative diseases. Its Progenitor Cell Activation approach, uses combinations of small molecules to activate progenitor cells within the body to create functional tissue. The company's lead product candidate is FX-322, which is in Phase IIa clinical trial to treat the underlying cause of sensorineural hearing loss. It is also developing medicines for patients across a range of... [Read more...]

Industry
Biotechnology
IPO Date
Oct 3, 2019
Stock Exchange
NASDAQ
Ticker Symbol
FREQ
Full Company Profile

Financial Performance

In 2020, FREQ's revenue was $36.98 million, an increase of 27.76% compared to the previous year's $28.95 million. Losses were -$26.51 million, 41.4% more than in 2019.

Financial Statements

Analyst Forecasts

According to 5 analysts, the average rating for FREQ stock is "Buy." The 12-month stock price forecast is 16.00, which is an increase of 105.13% from the latest price.

Price Target
$16.00
(105.13% upside)
Analyst Consensus: Buy